Lycopene feeding also reduced markers of liver damage including ALT and AST [14,16], and attenuated circulating levels of pro-inflammatory cytokine TNF-α [14], implicated in NAFLD progression. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.